 | • レポートコード：QYR9ST03716 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、サイレントがん治療の世界市場について調査・分析し、サイレントがん治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（腫瘍がん、脳がん、口腔及び喉頭がん、食道がん、肝臓がん、腎がん、膵臓がん、子宮頸がん、卵巣がん）、用途別（病院、外来手術センター、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のサイレントがん治療市場動向 ・主要企業別マーケットシェア ・サイレントがん治療の種類別市場規模2014-2019 （腫瘍がん、脳がん、口腔及び喉頭がん、食道がん、肝臓がん、腎がん、膵臓がん、子宮頸がん、卵巣がん） ・サイレントがん治療の用途別市場規模2014-2019 （病院、外来手術センター、クリニック、その他） ・サイレントがん治療の北米市場：主要企業・種類別/用途別市場規模 ・サイレントがん治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・サイレントがん治療の中国市場：主要企業・種類別/用途別市場規模 ・サイレントがん治療の日本国内市場：主要企業・種類別/用途別市場規模 ・サイレントがん治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・サイレントがん治療のインド市場：主要企業・種類別/用途別市場規模 ・サイレントがん治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott Laboratories、Amgen、Bayer、Bristol-Myers Squibb、GE Healthcare、Roche、Teva Pharmaceutical、GSK、CTI BioPharma、AstraZenec） ・サイレントがん治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Silent cancer refers to those types of cancer which are undiagnosed in early stages.The increasing prevalence of cancer is expected to drive the silent cancer therapeutic market over the forecast period.
In 2018, the global Silent Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Silent Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Silent Cancer Therapeutics development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Amgen
Bayer
Bristol-Myers Squibb
GE Healthcare
Roche
Teva Pharmaceutical
GSK
CTI BioPharma
AstraZenec
Market segment by Type, the product can be split into
Tumors Cancer
Brain Cancer
Mouth and Larynx Cancer
Esophagus Cancer
Liver Cancer
Renal Cancer
Pancreatic Cancer
Cervix Cancer
Ovarian Cancer
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Silent Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Silent Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Silent Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Silent Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Tumors Cancer
1.4.3 Brain Cancer
1.4.4 Mouth and Larynx Cancer
1.4.5 Esophagus Cancer
1.4.6 Liver Cancer
1.4.7 Renal Cancer
1.4.8 Pancreatic Cancer
1.4.9 Cervix Cancer
1.4.10 Ovarian Cancer
1.5 Market by Application
1.5.1 Global Silent Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Silent Cancer Therapeutics Market Size
2.2 Silent Cancer Therapeutics Growth Trends by Regions
2.2.1 Silent Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Silent Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Silent Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Silent Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Silent Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Silent Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Silent Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Silent Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Silent Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Silent Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Silent Cancer Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Silent Cancer Therapeutics Market Size (2014-2019)
5.2 Silent Cancer Therapeutics Key Players in United States
5.3 United States Silent Cancer Therapeutics Market Size by Type
5.4 United States Silent Cancer Therapeutics Market Size by Application
6 Europe
6.1 Europe Silent Cancer Therapeutics Market Size (2014-2019)
6.2 Silent Cancer Therapeutics Key Players in Europe
6.3 Europe Silent Cancer Therapeutics Market Size by Type
6.4 Europe Silent Cancer Therapeutics Market Size by Application
7 China
7.1 China Silent Cancer Therapeutics Market Size (2014-2019)
7.2 Silent Cancer Therapeutics Key Players in China
7.3 China Silent Cancer Therapeutics Market Size by Type
7.4 China Silent Cancer Therapeutics Market Size by Application
8 Japan
8.1 Japan Silent Cancer Therapeutics Market Size (2014-2019)
8.2 Silent Cancer Therapeutics Key Players in Japan
8.3 Japan Silent Cancer Therapeutics Market Size by Type
8.4 Japan Silent Cancer Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Silent Cancer Therapeutics Market Size (2014-2019)
9.2 Silent Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Silent Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Silent Cancer Therapeutics Market Size by Application
10 India
10.1 India Silent Cancer Therapeutics Market Size (2014-2019)
10.2 Silent Cancer Therapeutics Key Players in India
10.3 India Silent Cancer Therapeutics Market Size by Type
10.4 India Silent Cancer Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Silent Cancer Therapeutics Market Size (2014-2019)
11.2 Silent Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Silent Cancer Therapeutics Market Size by Type
11.4 Central & South America Silent Cancer Therapeutics Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Silent Cancer Therapeutics Introduction
12.1.4 Abbott Laboratories Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Silent Cancer Therapeutics Introduction
12.2.4 Amgen Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Silent Cancer Therapeutics Introduction
12.3.4 Bayer Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Silent Cancer Therapeutics Introduction
12.4.4 Bristol-Myers Squibb Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.4.5 Bristol-Myers Squibb Recent Development
12.5 GE Healthcare
12.5.1 GE Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Silent Cancer Therapeutics Introduction
12.5.4 GE Healthcare Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.5.5 GE Healthcare Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Silent Cancer Therapeutics Introduction
12.6.4 Roche Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Silent Cancer Therapeutics Introduction
12.7.4 Teva Pharmaceutical Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.7.5 Teva Pharmaceutical Recent Development
12.8 GSK
12.8.1 GSK Company Details
12.8.2 Company Description and Business Overview
12.8.3 Silent Cancer Therapeutics Introduction
12.8.4 GSK Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.8.5 GSK Recent Development
12.9 CTI BioPharma
12.9.1 CTI BioPharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Silent Cancer Therapeutics Introduction
12.9.4 CTI BioPharma Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.9.5 CTI BioPharma Recent Development
12.10 AstraZenec
12.10.1 AstraZenec Company Details
12.10.2 Company Description and Business Overview
12.10.3 Silent Cancer Therapeutics Introduction
12.10.4 AstraZenec Revenue in Silent Cancer Therapeutics Business (2014-2019)
12.10.5 AstraZenec Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Silent Cancer Therapeutics Key Market Segments
Table Key Players Silent Cancer Therapeutics Covered
Table Global Silent Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Silent Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure Tumors Cancer Figures
Table Key Players of Tumors Cancer
Figure Brain Cancer Figures
Table Key Players of Brain Cancer
Figure Mouth and Larynx Cancer Figures
Table Key Players of Mouth and Larynx Cancer
Figure Esophagus Cancer Figures
Table Key Players of Esophagus Cancer
Figure Liver Cancer Figures
Table Key Players of Liver Cancer
Figure Renal Cancer Figures
Table Key Players of Renal Cancer
Figure Pancreatic Cancer Figures
Table Key Players of Pancreatic Cancer
Figure Cervix Cancer Figures
Table Key Players of Cervix Cancer
Figure Ovarian Cancer Figures
Table Key Players of Ovarian Cancer
Table Global Silent Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Silent Cancer Therapeutics Report Years Considered
Table Global Silent Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Silent Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Silent Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Silent Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Silent Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Silent Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Silent Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Silent Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Silent Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Silent Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Silent Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Silent Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Silent Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Silent Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Silent Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Silent Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Silent Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Silent Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Silent Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Silent Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Silent Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Silent Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Silent Cancer Therapeutics Market Share (2018-2019)
Table United States Silent Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Silent Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Silent Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Silent Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Silent Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Silent Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Silent Cancer Therapeutics Market Share (2018-2019)
Table Europe Silent Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Silent Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Silent Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Silent Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Silent Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Silent Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Silent Cancer Therapeutics Market Share (2018-2019)
Table China Silent Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Silent Cancer Therapeutics Market Share by Type (2014-2019)
Table China Silent Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Silent Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Silent Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Silent Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Silent Cancer Therapeutics Market Share (2018-2019)
Table Japan Silent Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Silent Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Silent Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Silent Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Silent Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Silent Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Silent Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Silent Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Silent Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Silent Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Silent Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Silent Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Silent Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Silent Cancer Therapeutics Market Share (2018-2019)
Table India Silent Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Silent Cancer Therapeutics Market Share by Type (2014-2019)
Table India Silent Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Silent Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Silent Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Silent Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Silent Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Silent Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Silent Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Silent Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Silent Cancer Therapeutics Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Silent Cancer Therapeutics Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Amgen Company Details
Table Amgen Revenue in Silent Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table Bayer Company Details
Table Bayer Revenue in Silent Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Silent Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Silent Cancer Therapeutics Business (2014-2019)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table GE Healthcare Recent Development
Table Roche Company Details
Table Roche Revenue in Silent Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Silent Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table GSK Company Details
Table GSK Revenue in Silent Cancer Therapeutics Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table GSK Recent Development
Table CTI BioPharma Company Details
Table CTI BioPharma Revenue in Silent Cancer Therapeutics Business (2014-2019)(Million US$)
Figure CTI BioPharma Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table CTI BioPharma Recent Development
Table AstraZenec Company Details
Table AstraZenec Revenue in Silent Cancer Therapeutics Business (2014-2019)(Million US$)
Figure AstraZenec Revenue Growth Rate in Silent Cancer Therapeutics Business (2014-2019)
Table AstraZenec Recent Development
Table Global Silent Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Silent Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Silent Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Silent Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Silent Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Silent Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Silent Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Silent Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Silent Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Silent Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Silent Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Silent Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Silent Cancer Therapeutics Market Size by Product in 2025
Table Global Silent Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Silent Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Silent Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
卵巣癌遺伝子治療の世界市場：市場規模・現状・予測 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- 卵巣癌治療の世界市場：市場規模・現状・予測 Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products.In 2018, the global Ovarian Cancer Th…
- 膀胱がん治療の世界市場：市場規模・現状・予測 The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…
- 肛門癌治療の世界市場：市場規模・現状・予測 A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it m…
- 卵巣癌の世界市場：市場規模・現状・予測 Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer.North America dominates the global market for ovarian cancer due to large number of aging p…